Table of Contents
- Key Points
- Background: The Hype Around Anti-Aging Supplements
- What Is Vivix?
- The Harvard Researcher Behind the Buzz
- What Dr. Sinclair Said at the Shaklee Conference
- The Science of Resveratrol: From Red Wine to Pills
- The Fallout: Resignation and Legal Action
- Shaklee's Response: A Clash of Narratives
- Clinical Implications: What Patients Should Know
- Limitations of This Report
- Recommendations for Patients
- Frequently Asked Questions
- Source Information
Key Points
- Vivix is a Shaklee supplement containing resveratrol, marketed as an anti-aging tonic with dramatic claims.
- Harvard researcher David Sinclair was paid to advise Shaklee, but resigned after saying his name implied endorsement.
- Scientific advisory board roles are often paid consulting positions, not verification of product claims.
- Patients should look for clinical trial evidence, ask about conflicts of interest, and discuss supplements with their doctor.
Background: The Hype Around Anti-Aging Supplements
The Internet is full of products promising to slow aging, extend lifespan, and restore youthful vitality. Dietary supplements, in particular, occupy a strange middle ground: they are not held to the same rigorous standards as prescription drugs, yet they often make bold, life-changing claims in their marketing.
Vivix is one such product. Sold by Shaklee, a well-known supplement company, it was promoted online as "the world's best anti-aging supplement." It comes in a grape-flavored liquid form—a detail that makes it feel more like a health tonic than a pill bottle. If you were scrolling through health websites in 2008, you might easily have encountered glossy sales pages touting its supposed benefits.
What made Vivix stand out from the crowd, however, was not the formula itself. It was the name attached to it: David Sinclair, a Harvard researcher whose aging research had earned him serious attention in the scientific community. The idea that a credible academic was behind the product lent it an air of legitimacy—an impression that would become the center of a public dispute.
This case is not just about one researcher and one supplement. It is about how consumers can be influenced by endorsements, real or implied, and why it matters to understand the financial relationships behind medical and health-product claims.
What Is Vivix?
Vivix is a dietary supplement created by Shaklee, a company that has been selling nutritional products for decades. The product's central ingredient is a compound called resveratrol, a natural substance found in grapes, red wine, and certain berries.
The marketing materials for Vivix described it in glowing terms, positioning it as a breakthrough in anti-aging science. It was not just a vitamin; it was pitched as something that could tap into the body's own genetic pathways to slow the aging process. The idea was compelling enough that Shaklee salespeople were trained to present it as a cutting-edge product backed by top-tier science.
- Product: Vivix, a grape-flavored liquid supplement
- Active ingredient: Resveratrol, a polyphenol compound found in red wine and grapes
- Company: Shaklee, a supplement manufacturer with a long-established direct-sales network
- Claim: Marketed as "the world's best anti-aging supplement"
Shaklee's sales model relies heavily on independent distributors who sell products directly to friends, family, and acquaintances. This means that personal relationships—and personal trust—play an outsized role in how products like Vivix reach consumers.
The Harvard Researcher Behind the Buzz
David Sinclair is a geneticist and professor at Harvard Medical School who has spent much of his career studying the biology of aging. His research has been published in prestigious scientific journals, and he has been a prominent voice in the field of longevity science. By the late 2000s, his name carried significant weight in discussions about aging and how it might be slowed or even reversed.
Sinclair's connection to resveratrol was not incidental. His laboratory research suggested that resveratrol might activate certain genetic pathways—specifically, a family of proteins called sirtuins—that are believed to play a role in cellular health and longevity. This research is one of the reasons resveratrol became a hot topic in both scientific and commercial circles.
That scientific interest translated into serious money. Sinclair received $8 million when Sirtris, a biotech company focused on developing resveratrol-based drugs, was sold to pharmaceutical giant GlaxoSmithKline. He remained a consultant to the company after the sale. This financial stake in resveratrol's success is worth keeping in mind—scientists can have financial interests in the compounds they study, just as companies have interests in the products they sell.
At the same time as his academic and biotech work, Sinclair was paid to serve on the scientific advisory board of Shaklee. Advisory board roles like this are common in the supplement industry; companies pay researchers for their expertise, credibility, and guidance. But they also create the potential for a conflict of interest, especially when a researcher's scientific reputation becomes part of a product's marketing strategy.
What Dr. Sinclair Said at the Shaklee Conference
At a Shaklee sales conference in the summer of 2008, Sinclair addressed the company's salespeople. The Wall Street Journal obtained video of the event, and the content is striking.
According to the WSJ report, Sinclair told the sales force that "over a year ago, we set out together to do this, to make a product that you could actually activate these genetic pathways that can slow down aging." This language frames the product as a joint scientific mission between the researcher and the company—a collaboration with a shared goal.
He went further, saying: "Together, as part of the Shaklee family...we can take this technology right now, to our friends, to our family, and really have the benefits of this new technology right now, within our lifetimes."
The phrase "Shaklee family" and the invitation to share the "benefits" of the product with friends and family sound remarkably similar to the language of a sales pitch. To an outside observer, the distinction between "scientist presenting research" and "enthusiast selling a product" becomes quite blurry in moments like these.
It is worth noting that Sinclair was not simply an unpaid guest speaker. He was a paid member of the scientific advisory board, and the company's salespeople were being trained to use his scientific authority as a selling point. For the sales team, having a Harvard researcher stand on stage and talk about slowing aging was a powerful motivator—and a powerful marketing tool for the product they were expected to sell.
The Science of Resveratrol: From Red Wine to Pills
Resveratrol is a natural compound found in the skin of red grapes. It is present in red wine, which has long been the subject of research interest due to the "French paradox"—the observation that French people have relatively low rates of heart disease despite a diet rich in saturated fats, a phenomenon some scientists have attributed to regular red wine consumption.
Sinclair's research suggested that resveratrol might activate sirtuin proteins, which are involved in cellular regulation and have been linked to lifespan extension in some animal models. These findings generated substantial enthusiasm in the scientific community and beyond, leading to a wave of resveratrol-containing supplements hitting the market.
It is essential to understand the gap between laboratory findings and clinical reality. A compound that shows promise in a petri dish or in mice is a long way from being proven safe and effective in humans. The research on resveratrol in humans has produced mixed results, and no anti-aging drug or supplement has been approved by regulatory agencies on the basis of slowing human aging.
So when a product like Vivix is marketed as an "anti-aging tonic," it is riding on a wave of preliminary science that has been simplified, amplified, and commercialized. The science is real, in the sense that the research exists. But the leap from "resveratrol activates longevity genes in the lab" to "this grape-flavored drink will slow your aging" is a massive one—and it is a leap made in the marketing department, not in the laboratory.
The Fallout: Resignation and Legal Action
The turning point came when The Wall Street Journal contacted David Sinclair about his connection to Shaklee. Shortly after being asked about the relationship, Sinclair resigned from his advisory position at the company.
In a formal statement, Sinclair explained his decision: "This decision was prompted in significant part by my recent realization as to how my association with Shaklee and my research have been used contrary to the intents and purposes of my agreement."
He described his dismay at finding his name used in ways he had not intended: "To my dismay I have found numerous uses of my name and reputation on the Web and in other media that implies endorsement by me of Shaklee's Vivix product."
Sinclair stated that he had taken legal steps: "I have engaged counsel to deal with this matter and have demanded that Shaklee cease using my name."
In other words, the researcher who had once stood on stage at a Shaklee conference, speaking warmly about the "Shaklee family," was now actively trying to distance himself from the company and stop its use of his name. The shift from endorsement to legal action happened quickly, and it was prompted by an investigative question from a reporter.
Shaklee's Response: A Clash of Narratives
Shaklee, for its part, saw the situation very differently. The company issued its own statement addressing the dispute:
"Every implied product endorsement was in Dr. Sinclair's own words and every Shaklee use of his name—whether in print or video—was pre-approved by him in keeping with our agreement."
The two accounts are hard to reconcile. Sinclair says his name and reputation were used to imply endorsements he never gave. Shaklee says everything was pre-approved by Sinclair in accordance with their agreement. Both can technically be true in the murky world of endorsement deals: a person might approve specific uses of their name, only to later realize that the cumulative effect of those uses creates an impression they are uncomfortable with.
What is clear is that the relationship between a supplement company and a scientific advisor can be complicated, and the lines between legitimate engagement and problematic endorsement are not always obvious—even to the people involved. For consumers, this means that seeing a scientist's name attached to a product should not be mistaken for a guarantee of scientific validity.
Clinical Implications: What Patients Should Know
This story has several important lessons for patients and consumers who are considering dietary supplements.
First, scientific titles do not equal scientific endorsement. A Harvard affiliation is impressive, but the presence of a researcher's name on a product's advisory board does not mean the product has been proven to work. Paid advisory roles are common across the supplement industry, and they are often more about lending credibility than about rigorous scientific oversight.
Second, anti-aging claims should be viewed with skepticism. The headline claim behind Vivix—that it can "slow down aging"—is a dramatic one. As of the time of this report, no supplement has been proven to slow human aging in controlled clinical trials. Resveratrol is an interesting compound with promising laboratory research, but interesting laboratory research is not the same as proven clinical benefit.
Third, financial interests matter in science. Sinclair received $8 million from the sale of Sirtris, a company connected to resveratrol-based drugs. Financial interests do not automatically invalidate a researcher's work, but they do create conflicts that should be disclosed and considered. Patients should look for disclosure statements and think carefully about whether a researcher has a financial stake in the product or approach being promoted.
Fourth, supplement marketing can blur the line between information and sales. The language Sinclair used at the Shaklee conference—urging salespeople to share the "benefits" of the product "within our lifetimes"—sounds quite similar to the language used to sell the product to consumers. When the scientific presentation and the sales pitch become indistinguishable, patients need to be especially careful.
Limitations of This Report
This article is based on a news report from The Wall Street Journal, dated December 26, 2008, and it has inherent limitations that should be acknowledged.
The original piece was a single news article, not a systematic investigation or peer-reviewed study. It captures a snapshot of events at a particular moment in time. The full details of the Sinclair-Shaklee agreement were not made public, and the dispute between the researcher and company was, at the time of writing, an ongoing legal matter.
Additionally, this article does not evaluate whether Vivix is safe, effective, or harmful. It does not review the broader scientific literature on resveratrol or aging. The purpose is to examine the conflict-of-interest dynamics revealed by the WSJ investigation, not to draw conclusions about the product itself.
Readers should also note that events described took place in 2008. The scientific understanding of resveratrol and aging has evolved since that time, and Sinclair's later career has continued to develop. This article should be understood as a historical snapshot of an important moment in the intersection of science and supplement marketing.
Recommendations for Patients
If you are considering dietary supplements—especially those with bold anti-aging claims—here are practical steps to keep in mind:
- Look for evidence, not endorsements. A product should be evaluated based on the quality of clinical trials, not on the celebrity or academic status of the people associated with it.
- Check for independent research. Look for studies conducted by independent researchers, not by the company making the product or by researchers with financial ties to it.
- Ask about conflicts of interest. If a researcher, doctor, or celebrity is promoting a supplement, ask what financial relationship they have with the company. This information is not always volunteered.
- Be wary of dramatic claims. Phrases like "the world's best anti-aging supplement" are marketing language, not scientific conclusions. If something sounds too good to be true in the world of health, it often is.
- Talk to your healthcare provider. Before starting any supplement, discuss it with your doctor or pharmacist. They can help you weigh potential benefits, risks, and interactions with any medications you take.
- Understand what "advisory board" means. Serving on a scientific advisory board is often a paid consulting role. It does not mean the advisor has personally verified every claim the company makes.
The bottom line is simple: when you buy a supplement, be sure you know what you are buying, who is making money from it, and what the science actually shows. A famous name in science can add credibility to a product, but it cannot replace evidence.
Frequently Asked Questions
What is Vivix and who makes it?
Vivix is a dietary supplement made by Shaklee, a company selling nutritional products for decades. It is a grape-flavored liquid whose central ingredient is resveratrol, a natural compound found in grapes and red wine. Shaklee marketed it as an anti-aging supplement, claiming it could slow the aging process.
Did the Harvard researcher David Sinclair endorse Vivix?
Sinclair served as a paid scientific advisory board member for Shaklee. At a 2008 sales conference, he spoke enthusiastically about the product, but later resigned, saying his name was used to imply endorsement contrary to his agreement. Shaklee claimed every use was pre-approved. The dispute shows that association does not necessarily mean scientific endorsement.
What does it mean when a scientist serves on a supplement company's advisory board?
A scientific advisory board role is often a paid consulting position. It does not mean the advisor has personally verified every claim the company makes. In this case, the researcher was paid, and his scientific reputation became part of the product's marketing. This can create conflicts of interest that patients should consider.
Should I get a second opinion before taking an anti-aging tonic like Vivix promoted by a Harvard researcher?
Before buying an anti-aging supplement like Vivix, a second opinion helps when the product makes dramatic claims or leans on a researcher's reputation. A paid advisory board role does not mean the product has been clinically validated. Resveratrol has promising laboratory findings, but no supplement has been shown in controlled human trials to slow aging. Financial ties matter: researchers may profit from supplements they study, creating conflicts that should be disclosed. A second opinion can clarify whether the science supports the marketing and whether the supplement is necessary or an unnecessary expense. Diagnostic Detectives Network provides independent expert second opinions.
Source Information
This patient-friendly article is based on the following peer-reviewed and journalistic source:
- Original title: "Harvard Researcher Tied to Shaklee 'Anti-Aging Tonic' Vivix"
- Author: Jacob Goldstein
- Publication: The Wall Street Journal (Health Blog)
- Date: December 26, 2008
- URL: https://www.wsj.com/articles/BL-HEB-3860
This patient-friendly article is based on journalistic reporting from a reputable news source. The original report includes video footage of Dr. Sinclair's remarks at the Shaklee conference and statements from both David Sinclair and Shaklee. Readers seeking additional information about resveratrol, aging research, or supplement regulation should consult current scientific literature and speak with their healthcare providers.
